Latest Foreign Investment Review News

Page 12 of 23
Suzerain Investments Holdings Limited has initiated an off-market takeover bid for all remaining shares of Entertainment Rewards Ltd (EAT) at $0.022 per share, a substantial premium over recent trading prices. The offer comes with unanimous support from EAT's Independent Board Committee, subject to regulatory approvals and an independent expert's fairness opinion.
Claire Turing
Claire Turing
28 Oct 2025
Pearl Gull Iron Limited has entered a binding agreement to sell its Cockatoo Island Project for A$4.5 million in cash, a 4% equity interest in Crestlink Pty Ltd, and royalties on extracted materials, with completion expected in Q4 2025.
Maxwell Dee
Maxwell Dee
27 Oct 2025
Mad Paws Holdings Limited convened a pivotal Scheme Meeting to seek shareholder approval for its $61.5 million acquisition by Rover Group, Inc., with the Board unanimously backing the deal. Key conditions precedent have been met, setting the stage for final court approval and scheme implementation in November.
Victor Sage
Victor Sage
24 Oct 2025
Apiam Animal Health Limited has entered a binding agreement with Adamantem Capital Fund II for a $228.4 million acquisition via a scheme of arrangement, offering shareholders a significant premium and flexible cash or scrip consideration options.
Ada Torres
Ada Torres
22 Oct 2025
Mayne Pharma has announced the rescheduling of its Supreme Court hearing to November 3, 2025, to approve the acquisition scheme by Cosette Australia BidCo, pending Foreign Investment Review Board approval.
Ada Torres
Ada Torres
21 Oct 2025
United States Antimony Corporation has made a non-binding indicative offer to acquire Larvotto Resources at a significant premium, proposing a strategic merger focused on antimony supply chain security and growth.
Maxwell Dee
Maxwell Dee
20 Oct 2025
Mayne Pharma’s planned acquisition by Cosette Pharmaceuticals faces a delay as the Foreign Investment Review Board postpones its decision, potentially pushing back key court proceedings.
Victor Sage
Victor Sage
16 Oct 2025
Mayne Pharma has won a key legal battle against Cosette Pharmaceuticals, clearing the way for its acquisition scheme to proceed pending final approvals. Shareholders can expect the deal to move forward with payments scheduled soon.
Victor Sage
Victor Sage
16 Oct 2025
Entertainment Rewards’ majority shareholder Suzerain Investments has announced a $0.022 per share cash takeover offer, valuing the company at nearly $29 million and offering shareholders a substantial premium.
Sophie Babbage
Sophie Babbage
15 Oct 2025
Highfield Resources has locked in A$10 million through convertible notes from existing investors to tackle a key permit issue and push forward its flagship Muga Potash Project in Spain.
Maxwell Dee
Maxwell Dee
14 Oct 2025
IsoEnergy Ltd. is set to acquire Toro Energy Ltd., combining two significant uranium portfolios to create a diversified global player with flagship projects in Australia, Canada, and the U.S. This strategic merger positions the new entity to capitalize on rising uranium demand amid a tightening market.
Maxwell Dee
Maxwell Dee
13 Oct 2025
IsoEnergy Ltd. has agreed to acquire Toro Energy Ltd. in a deal that significantly expands its uranium portfolio, adding the Wiluna Uranium Project in Western Australia and creating a diversified, top-tier uranium development platform.
Maxwell Dee
Maxwell Dee
13 Oct 2025

Browse the archive

Full archive